TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CARCINOMA IN PREGNANCY WITH CISPLATIN-BASED CHEMOTHERAPY

被引:55
|
作者
KING, LA [1 ]
NEVIN, PC [1 ]
WILLIAMS, PP [1 ]
CARSON, LF [1 ]
机构
[1] UNIV MINNESOTA,SCH MED,DEPT OBSTET & GYNECOL,MINNEAPOLIS,MN 55455
关键词
D O I
10.1016/0090-8258(91)90259-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant ovarian neoplasms associated with pregnancy are uncommon, and the majority of these are Stage I. While adjuvant chemotherapy for germ cell tumors during pregnancy has been reported, only one previous report exists on the use of cisplatin-based chemotherapy for epithelial ovarian carcinomas during pregnancy. A patient with Stage III cystadenocarcinoma of the ovary treated during pregnancy with five courses of dose-intensive cisplatin and cyclophosphamide is presented. No adverse fetal effects secondary to cisplatin-based chemotherapy were noted. A review of the literature is presented. © 1991.
引用
收藏
页码:78 / 80
页数:3
相关论文
共 50 条
  • [31] Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
    Galsky, M. D.
    Chen, G. J.
    Oh, W. K.
    Bellmunt, J.
    Roth, B. J.
    Petrioli, R.
    Dogliotti, L.
    Dreicer, R.
    Sonpavde, G.
    ANNALS OF ONCOLOGY, 2012, 23 (02) : 406 - 410
  • [32] OPTIMAL DEBULKING FOLLOWING CHEMOTHERAPY OF ADVANCED-STAGE EPITHELIAL OVARIAN-CARCINOMA
    PIURA, B
    GLEZERMAN, M
    JOURNAL OF SURGICAL ONCOLOGY, 1989, 40 (04) : 237 - 240
  • [33] DOXORUBICIN AND CYCLOPHOSPHAMIDE, ALTERNATED WITH BLEOMYCIN AND MITOMYCIN-C AS A 2ND-LINE REGIMEN IN ADVANCED OVARIAN-CARCINOMA RESISTANT TO CISPLATIN-BASED CHEMOTHERAPY
    PANICI, PB
    SCAMBIA, G
    GREGGI, S
    SALERNO, G
    CENTO, R
    MANCUSO, S
    ONCOLOGY, 1990, 47 (04) : 296 - 298
  • [34] LONG-TERM SURVIVAL AFTER CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN-CARCINOMA
    WHARTON, JT
    EDWARDS, CL
    RUTLEDGE, FN
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 148 (07) : 997 - 1005
  • [35] CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK
    DEHAAN, LD
    DEMULDER, PHM
    VERMORKEN, JB
    SCHORNAGEL, JH
    VERMEY, A
    VERWEIJ, J
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1992, 14 (04): : 273 - 277
  • [36] IMPLICATIONS OF AN OVERVIEW OF CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA
    WILLIAMS, CJ
    BRITISH JOURNAL OF CANCER, 1992, 66 (02) : 225 - 226
  • [37] SEQUENTIAL COMBINATION CHEMOTHERAPY OF ADVANCED OVARIAN-CARCINOMA
    GUNALE, SR
    MURALI, MS
    YODER, AS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 430 - 430
  • [38] Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.
    Galsky, M. D.
    Chen, G. J.
    Oh, W. K.
    Bellmunt, J.
    Roth, B. J.
    Petrioli, R.
    Dogliotti, L.
    Dreicer, R.
    Sonpavde, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma
    Bellmunt, J
    Ribas, A
    Eres, N
    Albanell, J
    Almanza, C
    Bermejo, B
    Sole, LA
    Baselga, J
    CANCER, 1997, 80 (10) : 1966 - 1972
  • [40] Advanced ovarian cancer in elderly: results of consecutive trials with Cisplatin-based chemotherapy
    Chiara, S
    Vincenti, M
    Lionetto, R
    Pastorino, S
    Bruzzone, M
    Gadducci, A
    Carnino, F
    Rosso, R
    Conte, PF
    ANNALS OF ONCOLOGY, 1998, 9 : 62 - 62